Table 3.
Distribution of Cutaneous vs Noncutaneous Leiomyosarcoma (LMS) by Patient Agea
Age, y |
|||||
---|---|---|---|---|---|
Type of LMS | <50 | 50-59 | 60-69 | 70-79 | ≥80 |
Cutaneous | 24 | 15 | 19 | 48 | 69 |
Noncutaneous | 120 | 49 | 62 | 85 | 87 |
(P<.001).
Distribution of Cutaneous vs Noncutaneous Leiomyosarcoma (LMS) by Patient Agea
Age, y |
|||||
---|---|---|---|---|---|
Type of LMS | <50 | 50-59 | 60-69 | 70-79 | ≥80 |
Cutaneous | 24 | 15 | 19 | 48 | 69 |
Noncutaneous | 120 | 49 | 62 | 85 | 87 |
(P<.001).